Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Rasna Therapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Rasna Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
Rasna Therapeutics was formed in 2013 by a highly experienced industry team together with field-leading scientists, to focus on developing therapeutics to address the high unmet need that exists for AML and other forms of leukemia. Our primary indication
Telephone
Telephone
[+1] (646) 396-4080
Linkedin
Linkedin

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Actinomycin-D from Rasna Therapeutics will expand Tiziana Life Sciences's pipeline. The drug is on the WHO's List of Essential Medicines as the most effective medicines needed in a health system.


Lead Product(s): Dactinomycin

Therapeutic Area: Oncology Product Name: Undisclosed

Highest Development Status: UndisclosedProduct Type: Large molecule

Partner/Sponsor/Collaborator: Tiziana Life Sciences

Deal Size: $0.6 million Upfront Cash: $0.1 million

Deal Type: Acquisition April 24, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY